ciprofloxacin has been researched along with bilirubin in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Benet, LZ; Brouwer, KL; Chu, X; Dahlin, A; Evers, R; Fischer, V; Giacomini, KM; Hillgren, KM; Hoffmaster, KA; Huang, SM; Ishikawa, T; Keppler, D; Kim, RB; Lee, CA; Niemi, M; Polli, JW; Sugiyama, Y; Swaan, PW; Tweedie, DJ; Ware, JA; Wright, SH; Yee, SW; Zamek-Gliszczynski, MJ; Zhang, L | 1 |
| Marks, MI; Parker, KM; Stutman, HR | 1 |
| Ghosh, S; Luman, W; Palmer, KR | 1 |
| Chung, SC; Ismael, A; Lai, CW; Sollano, JD; Sung, JJ; Tumala, I; Yung, MY | 1 |
| Gong, Y; Johnson, J; Kneteman, N; Minuk, GY; Moser, M; Zhang, M | 1 |
| Bazin, C; Boytchev, I; Buffet, C; Choury, AD; Dhalluin-Venier, V; Farah, RB; Fritsch, J; Furlan, V; Massias, L; Pelletier, G; Prat, F | 1 |
| Akkiz, H; Cosar, A; Kece, C; Ozdil, B; Sandikci, M | 1 |
| Hawkins, K; Kaita, KD; Minuk, GY; Minuk, L; Renner, E; Uhanova, J; Wong, S | 1 |
| Baldan, HM; Brunetti, IL; Campos, ML; Davanço, MG; de Pontes Machado, DV; Filho, MA; Padilha, EC; Peccinini, RG; Pires, RV | 1 |
| Ahmad, E; Alam, P; Ansari, Y; Badr, G; Khan, RH; Varshney, A; Zaidi, N | 1 |
| Ali, MM; Ijaz, M; Muzammil, I; Saleem, MH | 1 |
1 review(s) available for ciprofloxacin and bilirubin
| Article | Year |
|---|---|
Membrane transporters in drug development.
Topics: Animals; Computer Simulation; Decision Trees; Drug Approval; Drug Discovery; Drug Evaluation, Preclinical; Drug Interactions; Humans; Membrane Transport Proteins; Mice; Mice, Knockout; Prescription Drugs | 2010 |
5 trial(s) available for ciprofloxacin and bilirubin
| Article | Year |
|---|---|
A combination of ciprofloxacin and Rowachol does not prevent biliary stent occlusion.
Topics: Aged; Alkaline Phosphatase; Anti-Infective Agents; Bile Duct Neoplasms; Bilirubin; Cholagogues and Choleretics; Cholestasis; Ciprofloxacin; Drug Combinations; Drug Therapy, Combination; Equipment Failure; Female; Follow-Up Studies; Frail Elderly; Humans; Male; Monoterpenes; Prospective Studies; Stents; Survival Rate; Terpenes | 1999 |
Long-term ciprofloxacin treatment for the prevention of biliary stent blockage: a prospective randomized study.
Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Anti-Infective Agents; Bile Duct Neoplasms; Bilirubin; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis; Cholestasis; Ciprofloxacin; Common Bile Duct Diseases; Equipment Design; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Middle Aged; Palliative Care; Pancreatic Neoplasms; Prospective Studies; Stents; Surface Properties; Time Factors | 1999 |
Effects of biliary obstruction on the penetration of ciprofloxacin and cefotaxime.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bile; Bilirubin; Cefotaxime; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis; Cholestasis; Chromatography, High Pressure Liquid; Ciprofloxacin; Female; Humans; Male; Middle Aged; Prospective Studies | 2008 |
Potential benefits of combined N-acetylcysteine and ciprofloxacin therapy in partial biliary obstruction.
Topics: Acetylcysteine; Aged; Anti-Infective Agents; Bile Ducts; Bilirubin; C-Reactive Protein; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis; Cholestasis; Ciprofloxacin; Dilatation, Pathologic; Double-Blind Method; Drug Synergism; Expectorants; Female; Humans; Male; Middle Aged; Pilot Projects; Severity of Illness Index; Sphincterotomy, Endoscopic; Ultrasonography | 2010 |
Daily ciprofloxacin treatment for patients with advanced liver disease awaiting liver transplantation reduces hospitalizations.
Topics: Adult; Anti-Infective Agents; Bilirubin; Ciprofloxacin; Female; Hospitalization; Humans; Liver Diseases; Liver Function Tests; Liver Transplantation; Male; Middle Aged; Prothrombin Time; Serum Albumin; Severity of Illness Index; Treatment Outcome | 2011 |
5 other study(ies) available for ciprofloxacin and bilirubin
| Article | Year |
|---|---|
Potential of moxalactam and other new antimicrobial agents for bilirubin-albumin displacement in neonates.
Topics: Anti-Bacterial Agents; Azlocillin; Aztreonam; Bilirubin; Binding Sites; Cefoperazone; Ciprofloxacin; Enoxacin; Humans; Imipenem; In Vitro Techniques; Infant, Newborn; Moxalactam; Naphthyridines; Quinolines; Serum Albumin; Thienamycins | 1985 |
Effect of preoperative interventions on outcome following liver resection in a rat model of cirrhosis.
Topics: Animals; Anti-Infective Agents; Aspartate Aminotransferases; Bilirubin; Ciprofloxacin; Diagnosis, Computer-Assisted; Fibrosis; Liver; Liver Cirrhosis, Experimental; Liver Regeneration; Male; Medicine, Chinese Traditional; Pentoxifylline; Phosphodiesterase Inhibitors; Preoperative Care; Proliferating Cell Nuclear Antigen; Rats; Rats, Sprague-Dawley; Survival Analysis; Thymidine | 2000 |
Pharmacokinetic and safety evaluation of the use of ciprofloxacin on an isoniazid-rifampicin regimen in rabbits.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Antibiotics, Antitubercular; Aspartate Aminotransferases; Bilirubin; Ciprofloxacin; Drug Combinations; Isoniazid; Male; Rabbits; Rifampin | 2012 |
Analysis of binding interaction between antibacterial ciprofloxacin and human serum albumin by spectroscopic techniques.
Topics: Anti-Bacterial Agents; Bilirubin; Binding Sites; Chloroform; Ciprofloxacin; Diazepam; Hemin; Humans; Hydrogen-Ion Concentration; Protein Binding; Protein Structure, Secondary; Serum Albumin; Spectrum Analysis | 2014 |
Drug repurposing strategy: An emerging approach to identify potential therapeutics for treatment of bovine mastitis.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Bilirubin; Cattle; Cefoxitin; Ciprofloxacin; Drug Repositioning; Female; Gentamicins; Ivermectin; Ketoprofen; Mastitis, Bovine; Meloxicam; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxytetracycline; Rabbits; Staphylococcal Infections; Sulfamethoxazole; Tylosin; Vancomycin | 2022 |